UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Oarsman Capital Inc.

Oarsman Capital Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,743 shares of the healthcare conglomerate’s stock after purchasing an additional 649 shares during the quarter. Oarsman Capital Inc.’s holdings in UnitedHealth Group were worth $2,400,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $341,000. Principal Financial Group Inc. lifted its stake in UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in UnitedHealth Group in the third quarter valued at $319,000. Texas Capital Bank Wealth Management Services Inc grew its holdings in UnitedHealth Group by 1.5% during the 3rd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,370 shares of the healthcare conglomerate’s stock worth $9,571,000 after acquiring an additional 236 shares in the last quarter. Finally, Temasek Holdings Private Ltd lifted its stake in UnitedHealth Group by 137.6% during the third quarter. Temasek Holdings Private Ltd now owns 161,656 shares of the healthcare conglomerate’s stock worth $94,517,000 after purchasing an additional 93,618 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 2.9 %

Shares of UNH opened at $524.94 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a 50 day simple moving average of $509.24 and a two-hundred day simple moving average of $542.37.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.